T1	Participants 142 194	patients with the acquired immunodeficiency syndrome
T2	Participants 551 721	310 adults with AIDS who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine
T3	Participants 1859 1976	There were 19 serious bacterial infections in the trimethoprim-sulfamethoxazole group and 38 in the pentamidine group
